| COMPANY |
Charles River Laboratories International, Inc. |
| COURT |
United States District Court for the District of Massachusetts |
| CASE NUMBER |
23-cv-11132 |
| JUDGE |
The Hon. Denise Jefferson Casper |
| CLASS PERIOD |
May 5, 2020 and February 21, 2023 |
| SECURITY TYPE |
Securities |
Case Background:
This is a class action lawsuit on behalf of those who purchased or acquired Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL) securities between May 5, 2020 and February 21, 2023, both dates inclusive (the “Class Period”).
On February 22, 2023, Charles River revealed that the company had received a subpoena from the U.S. Department of Justice relating to an ongoing investigation in conjunction with the U.S. Fish and Wildlife Service into the supply chain and illegal importation of non-human primates for research. On the same day, during an earnings call with investors, James C. Foster, the company’s CEO, stated that the “investigation in current [non-human primate] supply situation will result in study delays in our Safety Assessment business.” He further stated that the investigation into the Cambodian non-human primate chain would reduce the annual revenue forecast by approximately 200 basis points to 400 basis points.
Current Status of Case:
On November 14, 2023, Lead Plaintiff filed an Amended Complaint. Defendants filed a Motion to Dismiss the Amended Complaint on January 15, 2024. On July 1, 2024, the Court entered a Memorandum and Order granting Defendants’ Motion to Dismiss and entering Judgment in favor of the Defendants. Lead Plaintiff filed a Notice of Appeal as to the Judgment on July 30, 2024. This action is on appeal and ongoing
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jonathan Naji, Esq. (484) 270-1453 or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.